SEC 13F Intelligence

Managers / Q2 2020 · view latest →

Lion Point Capital, LP

CIK 0001643354 · 375 PARK AVE, SUITE 2609, NEW YORK, NY, 10152 · 212-356-6200

Reported Value
$412M
Q2 2020
Positions
24
Filings on Record
31
2019–present window
Filed
Aug 14, 2020
original filing

Summary

Lion Point Capital, LP reported $412M in U.S.-listed holdings across 24 positions for Q2 2020.

The portfolio is heavily concentrated: CSIQ alone accounts for 20.0% of reported value.

Compared with Q1 2020, the fund opened 3 new positions and exited 4.

Portfolio Metrics

Turnover
+30.1%
vs prior filed quarter
Top-10 Concentration
+76.3%
share of reported value
Largest Position
+20.0%
Canadian Solar
New / Exited
3 / 4
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $636MQ4 ’18Q1 ’19: $1.1BQ2 ’19: $1.0BQ3 ’19: $897MQ4 ’19: $1.1BQ4 ’19Q1 ’20: $379MQ2 ’20: $412MQ3 ’20: $456MQ4 ’20: $519MQ4 ’20Q1 ’21: $550MQ2 ’21: $579MQ3 ’21: $533MQ4 ’21: $373MQ4 ’21Q1 ’22: $431MQ2 ’22: $878MQ3 ’22: $454MQ4 ’22: $703MQ4 ’22Q1 ’23: $243MQ2 ’23: $221MQ3 ’23: $224MQ4 ’23: $200MQ4 ’23Q1 ’24: $179MQ2 ’24: $55MQ3 ’24: $45MQ4 ’24: $19MQ4 ’24Q1 ’25: $16MQ2 ’25: $15MQ3 ’25: $18MQ4 ’25: $19MQ4 ’25Q1 ’26: $17Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 85.7%Other: 11.3%ETP: 3.0%
  • Common Stock · 85.7% · $353M
  • Other · 11.3% · $47M
  • ETP · 3.0% · $12M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
TGTXTG THERAPEUTICS INCNEW+897.8K897.8K+$17M$17M
ARCONIC CORPORATIONNEW+1.17M1.17M+$16M$16M
AGLEUSDAEGLEA BIOTHERAPEUTICS INCNEW+300.0K300.0K+$3M$3M
ISHARES TRSOLD OUT−705.0K0−$81M$0
ARNCCHFARCONIC INCSOLD OUT−675.0K0−$11M$0
CPE3EURCALLON PETE CO DELSOLD OUT−8.20M0−$4M$0
XECEURCIMAREX ENERGY COSOLD OUT−35.2K0−$591,000$0
LSCCLATTICE SEMICONDUCTOR CORPTRIMMED−1.51M418.2K−$23M$12M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2020

22 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CSIQCANADIAN SOLAR INChistory →COM20.03%$83M4.29M
2DRRXEURDURECT CORPhistory →COM10.46%$43M18.59M
3ACHCACADIA HEALTHCARE COMPANY INhistory →COM9.49%$39M1.56M
4LIBERTY GLOBAL PLCSHS CL A · SHS CL C6.76%$28M1.27M
5MRNSUSDMARINUS PHARMACEUTICALS INChistory →COM6.70%$28M10.87M
6PRSPPERSPECTA INChistory →COM5.07%$21M900.0K
7SWCHFSIERRA WIRELESS INChistory →COM4.67%$19M2.14M
8AAALCOA CORPhistory →COM4.63%$19M1.70M
9PDCEUSDPDC ENERGY INChistory →COM4.42%$18M1.47M
10TGTXTG THERAPEUTICS INChistory →COM4.24%$17M897.8K
11ARCONIC CORPORATIONCOM3.95%$16M1.17M
12BATLBATTALION OIL CORPhistory →COM3.29%$14M1.43M
13KINIKSA PHARMACEUTICALS LTDCOM CL A3.06%$13M495.7K
14LSCCLATTICE SEMICONDUCTOR CORPhistory →COM2.88%$12M418.2K
15LUMOS PHARMA INCCOM1.63%$7M407.2K
16SCOR1EURCOMSCORE INChistory →COM1.44%$6M1.92M
17OUTFRONT MEDIA INCCOM1.03%$4M300.0K
18LOGCUSDLOGICBIO THERAPEUTICS INChistory →COM1.03%$4M500.0K
19EXTREXTREME NETWORKS INCCOM0.85%$4M811.8K
20AGLEUSDAEGLEA BIOTHERAPEUTICS INCCOM0.67%$3M300.0K
21OPES ACQUISITION CORPUNIT 03/07/20230.47%$2M83.4K
22OVVOVINTIV INCCOM0.21%$860,00090.1K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$17M35May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$19M39Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$18M27Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$15M19Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$16M21May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$19M19Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$45M25Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$55M27Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$179M32May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$200M30Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$224M31Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$221M30Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$243M31May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$703M32Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$454M41Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$878M40Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$431M35May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$373M33Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$533M38Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$579M34Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$550M30May 19, 2021RESTATEMENTchanges · EDGAR ↗
Q4 2020$519M24Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$456M24Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$412M24Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$379M25May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.1B26Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$897M26Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.0B24Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.1B24May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$636M35Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.